Kshama Pansare

About

Kshama Pansare received her Bachelor in Pharmacy from University of Pune, India, Masters in Biotechnology from University of Abertay Dundee, UK and PhD in Health Sciences from University of Glasgow and Aston University, UK in 2013. She received Engineering and Physical Sciences Research Council (EPSRC) funding for her PhD research along with research scholarship from Aston University and The Sir Richard Stapley Educational Trust, UK. She complted her Postdoctoral Research at Aston University, UK; NCCS, Pune; ACTREC, Mumbai; and IPR, Gujarat. Currently she is working as Senior Vice President Research and Innovation at Tzar Genomics India Pvt Ltd (Tzar Labs, India) and spearheading the cancer risk assessment HrC Test. Her research interests are Cancer Biology, Cancer Cell Signalling Networks, Radioresistance, identification of recurrent and novel variants in tumours using Next Generation Sequencing (NGS) approaches and Functional genomics.

Employment

• Tzar Genomics India Pvt Ltd (Previously Epigeneres Biotech Pvt. Ltd.) Senior Vice President
  2022 - Present
• Advanced Centre for Treatment Research and Education in Cancer Postdoctoral Research Associate
  2015 - 2022
• National Centre For Cell Science Postdoctoral Research Associate
  2013 - 2014

Education

• Aston University PhD
  2011 - 2012
• University of Glasgow PhD
  2009 - 2010
• University of Abertay Dundee Master of Science
  2005 - 2006
• University of Pune Bachelor of Pharmacy
  2000 - 2004

Projects & Funding

Projects & funding information is unavailable.

Publications (25)

• Cold Atmospheric Plasma Jet's Effect on Hamster Buccal Pouch Carcinogenesis: A Serum Raman Spectroscopy Study
  European Conferences on Biomedical Optics 2025 2025 DOI: 10.1364/ecbo.2025.w4a.5
  +Save
• Exploratory Raman Spectroscopic Studies of Canine Oral Tumour Types
  Journal of Biophotonics 2025 DOI: 10.1002/jbio.202400372
  +Save
• Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs
  Stem Cell Reviews and Reports 2024 DOI: 10.1007/s12015-024-10694-7
  +Save
• Candidates for early detection: Effect of pluripotent very small embryonic-like stem cells (VSELs) to transform into cancer stem cells (CSCs) and candidacy for early detection of cancer in a liquid biopsy.
  Journal of Clinical Oncology 2023 DOI: 10.1200/jco.2023.41.16_suppl.e15024
  +Save
• Raman Spectroscopy Revealed Cell Passage-Dependent Distinct Biochemical Alterations in Radiation-Resistant Breast Cancer Cells
  ACS Omega 2023 DOI: 10.1021/acsomega.2c06787
  +Save
• Serum Raman spectroscopy in experimental carcinogenesis hamster buccal pouch model: Exploring early diagnostic capability
  Journal of Raman Spectroscopy 2023 DOI: 10.1002/jrs.6450
  +Save
• Salivary Raman spectroscopy: Understanding alterations in saliva of tobacco habitués and oral cancer subjects
  Vibrational Spectroscopy 2022 DOI: 10.1016/j.vibspec.2022.103414
  +Save
• Monitoring Therapeutic Response in Cancers: A Raman Spectroscopy Approach
  Recent Advances in Analytical Techniques: Volume 5 2022 DOI: 10.2174/9789815036930122050007
  +Save
• Mitochondrial redox pathway activation and enhanced chromatin condensation of radiation-resistant breast cancer cells in hypoxic tumor microenvironment
  Journal of Radiation and Cancer Research 2022
  +Save
• Aspirin Inhibition of Group VI Phospholipase A2 Induces Synthetic Lethality in AAM Pathway Down-Regulated Gingivobuccal Squamous Carcinoma
  Cells 2021 DOI: 10.3390/cells11010123
  +Save